Sentences with phrase «clinical pharmacogenetics»

Mia Wadelius is Professor of Clinical Pharmacogenetics at Uppsala University and Senior Physician of Clinical Pharmacology at Akademiska Sjukhuset.

Dr. Relling is part of NIH's Pharmacogenomics Research Network and co-founder of CPIC, the Clinical Pharmacogenetics Implementation Consortium.

Molecular actions and clinical pharmacogenetics of lithium therapy.

He also actively participates in several major international consortium, such as International Warfarin Pharmacogenetic Consortium, International Clopidogrel Pharmacogenetic Consortium, Clinical Pharmacogenetics Implementation Consortium and worked with a group of experts to develop clinical use of HLA - B * 5801 and allopurinol.

He is a member of the Scientific Advisory Board of the Clinical Pharmacogenetic Implementation Consortium (CPIC) and a member of the CPIC informatics committee and has participated in guideline creation and review for that group.

Not exact matches

In clinical sciences, pharmacogenetics, with a particular emphasis on Asian populations, would represent another niche area.

In addition to warfarin, he is also in involves in other pharmacogenetic studies such as clopidogrel response, NSAID induced angioedema, drug induced Stevens - Johnson Syndrome and clinical studies using pharmacogenetic markers.

He is Director of the International (IFCC) Reference Center for Pharmacogenetics and he leads the Unit Research & Development of the Dept. Clinical Chemistry.

Ron H.N. van Schaik, PhD is a registered European Clinical Chemist (2003) andProfessor of Pharmacogenetics (2008).

Dr. Innocenti sits on the editorial board of Journal of Clinical Oncology, Pharmacogenetics and Genomics, Therapeutic Drug Monitoring, Current Drug Metabolism, and others.

- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing; Stephen Kimmel, MD, MSCE, Perelman School of Medicine at the University of Pennsylvania.

Today, the Golden Helix Foundation and the Section of Pharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learning actClinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learning actclinical research in pharmacogenomics, its clinical translation and educational and learning actclinical translation and educational and learning activities.

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing; Stephen Kimmel, MD, MSCE, Perelman School of Medicine at the University of Pennsylvania.

The Sections aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of drug - related pharmacogenetic databases and to create a population based biobank to conduct translational research in clinical pharmacogenomics.

Her primary interests are in treatment and pharmacogenetics of childhood leukemia and clinical implementation of pharmacogenetic testing.

184/6: 15 Assessing the clinical impact of ethnicity - specific pharmacogenetic allele variation in over 100,000 patients with biobank - linked electronic medical records.

The company was acquired in 2010 by Medco Health Solutions (with over 55 million Medco members) to provide pharmacogenetic testing services and clinical support focused on drug / gene interactions.

He participates in national and international advisory committees on pharmacogenetics, a.o. IFCC Task Force Pharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European Medicipharmacogenetics, a.o. IFCC Task Force Pharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Working Group of the European Medicine Agency (EMA).

Pharmacogenetics: This branch is related to the clinical testing of genetic variation that primarily gives rise to the differing response to human - made drugs.